Clinical Trial Update: A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder [Phase 1]

View source ↗

Summary

A Phase 1 randomized, placebo-controlled trial is evaluating the efficacy of propantheline to treat overactive bladder associated with HTLV-1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Propantheline (propantheline)

Snippet

Sponsor: Hospital Universitário Professor Edgard Santos | Conditions: Overactive Bladder Associated With HTLV-1 | Phase 1 | Status: UNKNOWN